Compile Data Set for Download or QSAR
maximum 50k data
Found 376 with Last Name = 'lawrence' and Initial = 'da'
TargetUrokinase-type plasminogen activator(Mus musculus (Mouse))
University of Michigan

LigandPNGBDBM92479(Tannic Acid, A | Tannic acid)
Affinity DataIC50:  4.10nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92479(Tannic Acid, A | Tannic acid)
Affinity DataIC50:  6.60nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92479(Tannic Acid, A | Tannic acid)
Affinity DataIC50:  7nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92479(Tannic Acid, A | Tannic acid)
Affinity DataIC50:  8nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92485(CDE-066 | US9120744, CDE-066)
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM175525(US9120744, CDE-001 (or 073))
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM175528(US9120744, CDE-004)
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM175526(US9120744, CDE-002)
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM175527(US9120744, CDE-003)
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUrokinase-type plasminogen activator(Mus musculus (Mouse))
University of Michigan

LigandPNGBDBM92485(CDE-066 | US9120744, CDE-066)
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92485(CDE-066 | US9120744, CDE-066)
Affinity DataIC50:  10nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTissue-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92485(CDE-066 | US9120744, CDE-066)
Affinity DataIC50:  12nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92486(CDE-082 | US9120744, CDE-082)
Affinity DataIC50:  14nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92486(CDE-082 | US9120744, CDE-082)
Affinity DataIC50:  18nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92487(CDE-031 | US9120744, CDE-031)
Affinity DataIC50:  20nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92487(CDE-031 | US9120744, CDE-031)
Affinity DataIC50:  28nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264615(US9718760, C182)
Affinity DataIC50:  33nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264650(US9718760, C204)
Affinity DataIC50:  35nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92482(CDE-008 | US9120744, CDE-008)
Affinity DataIC50:  44nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM175546(US9120744, CDE-061)
Affinity DataIC50:  50nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM175544(US9120744, CDE-058)
Affinity DataIC50:  50nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264630(US9718760, C198)
Affinity DataIC50:  51nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM175558(US9120744, CDE-075)
Affinity DataIC50:  70nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92484(CDE-056 | US9120744, CDE-056)
Affinity DataIC50:  74nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Mus musculus (Mouse))
University of Michigan

LigandPNGBDBM92486(CDE-082 | US9120744, CDE-082)
Affinity DataIC50:  79nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92484(CDE-056 | US9120744, CDE-056)
Affinity DataIC50:  86nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM175548(US9120744, CDE-059)
Affinity DataIC50:  90nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM50070942((-)-Epigallocatechin gallate | (-)-Epigallocatechi...)
Affinity DataIC50:  91nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92483(CDE-034 | US9120744, CDE-034)
Affinity DataIC50:  116nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264611(US9718760, C188)
Affinity DataIC50:  120nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUrokinase-type plasminogen activator(Mus musculus (Mouse))
University of Michigan

LigandPNGBDBM92487(CDE-031 | US9120744, CDE-031)
Affinity DataIC50:  132nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Mus musculus (Mouse))
University of Michigan

LigandPNGBDBM92482(CDE-008 | US9120744, CDE-008)
Affinity DataIC50:  162nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264602(US9718760, C197)
Affinity DataIC50:  173nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTissue-type plasminogen activator(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92483(CDE-034 | US9120744, CDE-034)
Affinity DataIC50:  174nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264616(US9718760, C183)
Affinity DataIC50:  180nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264613(US9718760, C157)
Affinity DataIC50:  250nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92487(CDE-031 | US9120744, CDE-031)
Affinity DataIC50:  280nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM50310309(CHEMBL596879 | N-(3,4-dihydroxyphenylsulfonyl)-N-h...)
Affinity DataIC50:  284nMAssay Description:Inhibition of human recombinant PAI1 assessed as rate of AMC release after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264609(US9718760, C163)
Affinity DataIC50:  288nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92480(Epigallocatechin-3,5-Digallate, C)
Affinity DataIC50:  330nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264610(US9718760, C165)
Affinity DataIC50:  350nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM92482(CDE-008 | US9120744, CDE-008)
Affinity DataIC50:  370nMpH: 7.8 T: 2°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264645(US9718760, C185)
Affinity DataIC50:  420nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264646(US9718760, C196)
Affinity DataIC50:  450nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1/Tissue-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264610(US9718760, C165)
Affinity DataIC50:  510nMT: 2°CAssay Description:PAI-1 inhibitor compounds were dissolved in DMSO to a final concentration of (10-50 mM), depending upon solubility. Compounds were then diluted in ph...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264644(US9718760, C184)
Affinity DataIC50:  590nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1(Homo sapiens (Human))
University of Michigan

LigandPNGBDBM50310311(CHEMBL601265 | N-cyclohexyl-N-(3,4-dihydroxyphenyl...)
Affinity DataIC50:  594nMAssay Description:Inhibition of human recombinant PAI1 assessed as rate of AMC release after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1/Tissue-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264609(US9718760, C163)
Affinity DataIC50:  611nMT: 2°CAssay Description:PAI-1 inhibitor compounds were dissolved in DMSO to a final concentration of (10-50 mM), depending upon solubility. Compounds were then diluted in ph...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen activator inhibitor 1/Urokinase-type plasminogen activator(Homo sapiens (Human))
University of Michigan

US Patent
LigandPNGBDBM264643(US9718760, C176)
Affinity DataIC50:  620nMpH: 7.4 T: 2°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUrokinase-type plasminogen activator(Mus musculus (Mouse))
University of Michigan

LigandPNGBDBM92483(CDE-034 | US9120744, CDE-034)
Affinity DataIC50:  644nMpH: 7.8 T: 2°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 376 total ) | Next | Last >>
Jump to: